For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
Join global healthcare leaders at ISPOR EU 2023 in Copenhagen as we gather to focus on the evolution in healthcare policy to address issues around the use of RWE, cross-border collaboration, affordability, and equity.
Please visit our booth (#C3-081) to meet more than 15 experts from our Market Access and HEOR Consulting, COA and Epidemiology and Real World Evidence teams.
Discuss landscaping for your product positioning, evolving trends in joint assessments and collaboration across HTAs – well as the long-term impact of new health policy initiatives on reimbursement and coverage. With novel AI and data analytics approaches that can help with your value demonstration, and differentiators for the communication of clinical, economic, and real-world data too – our team is always available for a conversation.
Senior Pricing & Market Access Consultant
Speaker | Monday, November 13th from 10:15 am - 11:15 am
International Reference Pricing and Joint Clinical Assessments—How Will European-Level HTA Evaluations Impact International Reference Pricing and Launch Sequencing?
Senior Director, HEOR, Evidence Evaluation, Access Consulting
Panelist | Monday, November 13th from 3:15 pm - 4:15 pm CET
Navigating the AI Revolution in Health Technology Assessments: Balancing Bias, Ethics, Time, Quality, and Evergreen Evidence
With more than 40 abstracts accepted at this ISPOR meeting, we have a wealth of actionable learnings and insight to share.
Watch Rito Bergemann, MD, PhD and Jacqueline Vanderpuye-Orgle, MSc, PhD in their HEOR Theater presentation at ISPOR US in Boston, discussing the use of AI to develop health economic evidence for optimized patient access.
Are you interested in meeting with our experts at this event? Please fill out the form below, and we'll contact you with more details.